Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1074 | 1010 | 1271 | 996 | 1508 | 2655 |
Fund Return | 7.43% | 1.02% | 27.12% | -0.12% | 8.56% | 10.26% |
Place in category | 407 | 467 | 418 | 128 | 326 | 154 |
% in Category | 76 | 81 | 81 | 35 | 72 | 42 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Great-West S&P 500 Index Init | 5.14B | 20.42 | 8.50 | 12.40 | ||
Great-West International Index Init | 1.68B | 6.38 | 2.14 | 4.72 | ||
Great-West Moderate Profile II Init | 1.61B | 8.29 | 2.56 | 5.99 | ||
Great-West S&P 500 Index Instituti | 1.35B | 20.77 | 8.88 | - | ||
Great-West Conservative Profile II | 1.13B | 5.42 | 1.16 | 3.76 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Principal MidCap Institutional | 15.13B | 18.77 | 5.53 | 12.65 | ||
T. Rowe Price Mid-Cap Growth I | 13.72B | 7.79 | 0.27 | - | ||
T. Rowe Price Mid-Cap Growth | 12.77B | 7.68 | 0.14 | 10.48 | ||
Vanguard Mid-Cap Growth Index Admir | 12.09B | 11.75 | -0.99 | 10.25 | ||
T. Rowe Price New Horizons I | 11.02B | 3.91 | -9.99 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Marvell | US5738741041 | 2.97 | 90.10 | -3.26% | |
Microchip | US5950171042 | 2.86 | 67.87 | -0.79% | |
Hologic | US4364401012 | 2.77 | 79.44 | +0.56% | |
The Trade Desk | US88339J1051 | 2.46 | 128.15 | -0.64% | |
Teleflex | US8793691069 | 2.11 | 192.00 | +0.52% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review